Vered Aviv is currently the Portfolio Director at Orgenesis Inc., a position held since 2020. Previously, they served as a Project Portfolio Manager at Orgenesis Inc. from 2018 to 2020 and as a Research Manager at Orgenesis Ltd. from 2014 to 2017. From 2017 to 2018, Vered worked as a Project Manager and scientist at ATVIO Biotech Ltd. Vered earned a PhD in Cell Therapy for Diabetes Mellitus from Tel Aviv University and holds a BSc in Biology from the same institution.
This person is not in the org chart
This person is not in any teams
This person is not in any offices